$SRNE - Sorrento is pressuring attention. With the acquisition of ACEA and hopefully ANP soon; SRNE cannot be ignored by Gov’t. Biden campaign probably figured this out about 3 weeks ago. My overly bullish thesis is that SRNE was probably not considered as 1 of 6 contracts originally until administration started doing some analysis on where they want to be this Summer. SRNE is going to land a huge contract. Variants will still outpace vaccines so Stix is no longer a threat on big pharm.
View original message